Death Without Prior Appropriate Implantable Cardioverter-Defibrillator Therapy
Author(s) -
Michael Koller,
Beat Schaer,
Marcel Wolbers,
Christian Sticherling,
Heiner C. Bucher,
Stefan Osswald
Publication year - 2008
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.107.742155
Subject(s) - medicine , cumulative incidence , ventricular fibrillation , implantable cardioverter defibrillator , population , sudden cardiac death , incidence (geometry) , heart failure , clinical endpoint , cardiology , sudden death , randomized controlled trial , cohort , physics , environmental health , optics
Implantable cardioverter-defibrillators (ICDs) improve survival in selected patients with left ventricular systolic dysfunction in randomized trials. Competing death without prior appropriate ICD therapy might preclude benefit from ICD implantation in a less selected routine-care population.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom